Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00040274 · ClinicalTrials.gov registry record · Phase 1
A Study of DPC 817 in HIV-Infected Males
A Phase 1 study, sponsored by Pharmasset.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00040274: Completed Phase 1 study, sponsored by Pharmasset.
NCT00040274 is a Phase 1 study that has completed, run by Pharmasset. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00040274, a Phase 1 study, has completed, sponsored by Pharmasset.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate DPC 817. The safety, dosages, and how the body responds to the drug will be studied.
Interventions
- DRUG DPC 817
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00040274
The ClinicalTrials.gov registry entry for NCT00040274 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pharmasset, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DPC 817 is the first listed.
NCT00040274 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00040274 about?
NCT00040274 is a clinical study titled "A Study of DPC 817 in HIV-Infected Males". The purpose of this study is to evaluate DPC 817. The safety, dosages, and how the body responds to the drug will be studied.
What is the current status of trial NCT00040274?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants.
What interventions are being tested in trial NCT00040274?
The interventions under investigation include: DPC 817 (DRUG).
Who is sponsoring clinical trial NCT00040274?
This trial is sponsored by Pharmasset, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.